CRDF Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2024-03-07 | Levine James E. | officer: Chief Financial Officer | 962,496 | A-Award | A | 205,008 | 3.51 | 719,578.00 |
2024-03-07 | Kabbinavar Fairooz | officer: Chief Medical Officer | 630,008 | A-Award | A | 205,008 | 3.51 | 719,578.00 |
2024-03-07 | Smeal Tod | officer: Chief Scientific Officer | 647,184 | A-Award | A | 205,008 | 3.51 | 719,578.00 |
2024-03-07 | Erlander Mark | director, officer: Chief Executive Officer | 2,170,310 | A-Award | A | 510,000 | 3.51 | 1,790,100.00 |
2023-12-19 | PACE GARY W | director | 697,761 | P-Purchase | A | 30,000 | 1.37 | 41,100.00 |
2023-11-10 | PACE GARY W | director | 667,761 | P-Purchase | A | 22,950 | 0.98 | 22,491.00 |
2023-06-15 | Markin Rodney S | director | 152,327 | A-Award | A | 27,700 | 1.59 | 44,043.00 |
2023-06-15 | Armitage James O | director | 117,274 | A-Award | A | 27,700 | 1.59 | 44,043.00 |
2023-06-15 | White Lale | director | 117,274 | A-Award | A | 27,700 | 1.59 | 44,043.00 |
2023-06-15 | PACE GARY W | director | 117,274 | A-Award | A | 27,700 | 1.59 | 44,043.00 |
2023-06-15 | Mohindru Mani | director | 98,501 | A-Award | A | 27,700 | 1.59 | 44,043.00 |
2023-06-15 | TANNENBAUM RENEE P | director | 98,501 | A-Award | A | 27,700 | 1.59 | 44,043.00 |
2023-03-15 | Smeal Tod | officer: Chief Scientific Officer | 442,176 | A-Award | A | 167,088 | 1.72 | 287,391.00 |
2023-03-15 | Levine James E. | officer: Chief Financial Officer | 757,488 | A-Award | A | 197,472 | 1.72 | 339,652.00 |
2023-03-15 | Kelemen Vicki | officer: Exec. VP and COO | 698,304 | A-Award | A | 125,520 | 1.72 | 215,894.00 |
2023-03-15 | Erlander Mark | director, officer: Chief Executive Officer | 1,664,477 | A-Award | A | 482,064 | 1.72 | 829,150.00 |
2023-01-30 | Kabbinavar Fairooz | officer: Chief Medical Officer | 0 | D | 425,000 | 1.75 | 743,750.00 | |
2022-11-25 | Erlander Mark | officer: Chief Executive Officer | 24,481 | P-Purchase | A | 10,000 | 1.43 | 14,300.00 |
2022-09-16 | Armitage James O | director | 13,000 | P-Purchase | A | 13,000 | 1.56 | 20,233.00 |
2022-09-19 | White Lale | director | 113,788 | P-Purchase | A | 15,000 | 1.64 | 24,525.00 |
2022-09-15 | TANNENBAUM RENEE P | director | 10,000 | P-Purchase | A | 3,600 | 1.72 | 6,192.00 |
2022-09-15 | TANNENBAUM RENEE P | director | 6,400 | P-Purchase | A | 6,400 | 1.72 | 10,976.00 |
2022-09-15 | PACE GARY W | director | 644,811 | P-Purchase | A | 150,000 | 1.71 | 256,500.00 |
2022-09-16 | Levine James E. | officer: Chief Financial Officer | 60,000 | P-Purchase | A | 30,000 | 1.56 | 46,710.00 |
2022-07-05 | White Lale | director: | 98,788 | M-Exempt | A | 28,858 | 2.60 | 75,031.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 530 | 51.84 | 27,475.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 223 | 372.96 | 83,170.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 223 | 516.96 | 115,282.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 195 | 316.08 | 61,636.00 |
2022-06-09 | BRANCACCIO JOHN P | director: | 125,317 | J-Other | A | 22,000 | 0.00 | 0.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 26,800 | 2.50 | 67,000.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 22,000 | 7.98 | 175,560.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 28,858 | 2.60 | 75,031.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 44,734 | 2.48 | 110,940.00 |
2022-06-09 | BRANCACCIO JOHN P | other: Former Director | 125,317 | J-Other | A | 755 | 21.60 | 16,308.00 |
2022-03-09 | PACE GARY W | director: | 89,574 | A-Award | A | 26,800 | 0.00 | 0.00 |
2022-03-09 | PACE GARY W | director | 89,574 | A-Award | A | 26,800 | 2.50 | 67,000.00 |
2022-03-09 | White Lale | director: | 89,574 | A-Award | A | 26,800 | 0.00 | 0.00 |
2022-03-09 | TANNENBAUM RENEE P | director: | 70,801 | A-Award | A | 26,800 | 0.00 | 0.00 |
2022-03-09 | TANNENBAUM RENEE P | director | 70,801 | A-Award | A | 26,800 | 2.50 | 67,000.00 |
2022-03-09 | Ruffner Katherine L | officer: Chief Medical Officer | 370,016 | A-Award | A | 170,016 | 0.00 | 0.00 |
2022-03-09 | Mohindru Mani | director: | 70,801 | A-Award | A | 26,800 | 0.00 | 0.00 |
2022-03-09 | Mohindru Mani | director | 70,801 | A-Award | A | 26,800 | 2.50 | 67,000.00 |
2022-03-09 | Markin Rodney S | director: | 124,627 | A-Award | A | 26,800 | 0.00 | 0.00 |
2022-03-09 | Markin Rodney S | director | 124,627 | A-Award | A | 26,800 | 2.50 | 67,000.00 |
2022-03-09 | Levine James E. | officer: Chief Financial Officer | 560,016 | A-Award | A | 170,016 | 0.00 | 0.00 |
2022-03-09 | Kelemen Vicki | officer: Exec. VP and COO | 572,784 | A-Award | A | 170,016 | 0.00 | 0.00 |
2022-03-09 | Kelemen Vicki | officer: Exec. VP and COO | 572,784 | A-Award | A | 170,016 | 2.50 | 425,040.00 |
2022-03-09 | Erlander Mark | officer: Chief Executive Officer | 1,185,400 | A-Award | A | 370,128 | 0.00 | 0.00 |
2022-03-09 | Erlander Mark | director, officer: Chief Executive Officer | 1,185,400 | A-Award | A | 370,128 | 2.50 | 925,320.00 |
2022-03-09 | BRANCACCIO JOHN P | director: | 125,317 | A-Award | A | 26,800 | 0.00 | 0.00 |
2022-03-09 | BRANCACCIO JOHN P | director | 125,317 | A-Award | A | 26,800 | 2.50 | 67,000.00 |
2022-03-09 | Armitage James O | director: | 89,574 | A-Award | A | 26,800 | 0.00 | 0.00 |
2022-01-10 | Smeal Tod | officer: Chief Scientific Officer | 0 | D | 275,088 | 6.58 | 1,810,079.00 | |
2021-09-21 | PACE GARY W | director | 494,811 | P-Purchase | A | 30,000 | 6.75 | 202,500.00 |
2021-09-10 | Levine James E. | officer: Chief Financial Officer | 30,000 | P-Purchase | A | 5,000 | 6.32 | 31,600.00 |
2021-09-10 | Levine James E. | officer: Chief Financial Officer | 25,000 | P-Purchase | A | 5,000 | 6.35 | 31,750.00 |
2021-09-10 | Levine James E. | officer: Chief Financial Officer | 20,000 | P-Purchase | A | 10,000 | 6.38 | 63,800.00 |
2021-09-10 | Levine James E. | officer: Chief Financial Officer | 10,000 | P-Purchase | A | 5,000 | 6.75 | 33,750.00 |
2021-09-10 | Levine James E. | officer: Chief Financial Officer | 5,000 | P-Purchase | A | 5,000 | 6.62 | 33,100.00 |
2021-07-12 | Ruffner Katherine L | officer: Chief Medical Officer | 200,000 | A-Award | A | 200,000 | 6.55 | 1,310,000.00 |
2021-07-06 | Ruffner Katherine L | officer | 0 | 0 | 0.00 | 0.00 | ||
2021-07-12 | Levine James E. | officer: Chief Financial Officer | 390,000 | A-Award | A | 390,000 | 6.55 | 2,554,500.00 |
2021-07-12 | Levine James E. | officer | 0 | 0 | 0.00 | 0.00 | ||
2021-06-10 | JACOB GARY S | 76,106 | J-Other | A | 28,858 | 2.60 | 75,031.00 | |
2021-06-10 | JACOB GARY S | 76,106 | J-Other | A | 293 | 447.84 | 131,217.00 | |
2021-06-10 | JACOB GARY S | 76,106 | J-Other | A | 218 | 316.08 | 68,905.00 | |
2021-06-10 | JACOB GARY S | 76,106 | J-Other | A | 223 | 516.96 | 115,282.00 | |
2021-06-10 | JACOB GARY S | 76,106 | J-Other | A | 223 | 372.96 | 83,170.00 | |
2021-06-10 | JACOB GARY S | 76,106 | J-Other | A | 530 | 51.84 | 27,475.00 | |
2021-06-10 | JACOB GARY S | 76,106 | J-Other | A | 755 | 21.60 | 16,308.00 | |
2021-06-10 | JACOB GARY S | 76,106 | J-Other | A | 44,734 | 2.48 | 110,940.00 | |
2021-06-10 | White Lale | director | 62,774 | A-Award | A | 22,000 | 7.98 | 175,560.00 |
2021-06-10 | TANNENBAUM RENEE P | director | 44,001 | A-Award | A | 44,001 | 7.98 | 351,128.00 |
2021-06-10 | PACE GARY W | director | 62,774 | A-Award | A | 22,000 | 7.98 | 175,560.00 |
2021-06-10 | Mohindru Mani | director | 44,001 | A-Award | A | 44,001 | 7.98 | 351,128.00 |
2021-06-10 | Markin Rodney S | director | 97,827 | A-Award | A | 22,000 | 7.98 | 175,560.00 |
2021-06-10 | Kelemen Vicki | officer: Exec. VP and COO | 402,768 | A-Award | A | 200,928 | 7.98 | 1,603,405.00 |
2021-06-10 | Erlander Mark | director, officer: Chief Executive Officer | 815,272 | A-Award | A | 435,072 | 7.98 | 3,471,875.00 |
2021-06-10 | BRANCACCIO JOHN P | director | 98,517 | A-Award | A | 22,000 | 7.98 | 175,560.00 |
2021-06-10 | Armitage James O | director | 62,774 | A-Award | A | 22,000 | 7.98 | 175,560.00 |
2021-06-10 | ADAMS THOMAS PHD | 477,870 | J-Other | A | 298,320 | 2.48 | 739,834.00 | |
2021-06-10 | ADAMS THOMAS PHD | 477,870 | J-Other | A | 272 | 447.84 | 121,812.00 | |
2021-06-10 | ADAMS THOMAS PHD | 477,870 | J-Other | A | 223 | 7.18 | 1,601.00 | |
2021-06-10 | ADAMS THOMAS PHD | 477,870 | J-Other | A | 223 | 5.18 | 1,155.00 | |
2021-06-10 | ADAMS THOMAS PHD | 477,870 | J-Other | A | 530 | 51.84 | 27,475.00 | |
2021-06-10 | ADAMS THOMAS PHD | 477,870 | J-Other | A | 755 | 21.60 | 16,308.00 | |
2021-06-10 | ADAMS THOMAS PHD | 477,870 | J-Other | A | 173,145 | 2.60 | 450,177.00 | |
2021-06-10 | TANNENBAUM RENEE P | director: | 0 | 0 | 0.00 | 0.00 | ||
2021-06-10 | Mohindru Mani | director: | 0 | 0 | 0.00 | 0.00 | ||
2021-03-19 | Armitage James O | director | 14,490 | P-Purchase | A | 4,000 | 10.82 | 43,271.00 |
2021-03-26 | Markin Rodney S | director | 23,879 | P-Purchase | A | 2,900 | 10.32 | 29,933.00 |
2021-03-23 | PACE GARY W | director | 464,811 | P-Purchase | A | 2,500 | 10.31 | 25,775.00 |
2021-03-23 | PACE GARY W | director | 462,311 | P-Purchase | A | 2,500 | 10.21 | 25,525.00 |
2021-03-23 | PACE GARY W | director | 459,811 | P-Purchase | A | 5,000 | 10.20 | 51,000.00 |
2021-03-23 | JACOB GARY S | director | 21,922 | P-Purchase | A | 470 | 10.40 | 4,886.00 |
2021-03-23 | JACOB GARY S | director | 21,452 | P-Purchase | A | 1,900 | 10.42 | 19,804.00 |
2021-03-23 | Kelemen Vicki | officer: Exec. VP and COO | 6,053 | P-Purchase | A | 960 | 10.31 | 9,898.00 |
2021-03-23 | Erlander Mark | officer: Chief Executive Officer | 14,481 | P-Purchase | A | 965 | 10.34 | 9,980.00 |
2021-03-22 | BRANCACCIO JOHN P | director | 12,260 | P-Purchase | A | 3,000 | 10.95 | 32,850.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.